TransplantID Journal

The TID journal targets experts who study, diagnose, treat & prevent infectious complications in SOT, HCT & Heme/Onc patients #TxID #transplant #IDtwitter

[TransplantID Journal @TheTxIDjournal]

Consider applying for as an editor of @TheTxIDjournal!

If you have specific questions, please send them to [email protected].

4/4

[TransplantID Journal @TheTxIDjournal]

@TheTxIDjournal is seeking applications for those interested in joining the editorial team (https://t.co/AZP3ApjjKU) as an Associate Editor.  We are specifically seeking someone who has clinical and research experience focused on HSCT and/or Oncology ID for this position. 

1/4

[TransplantID Journal @TheTxIDjournal]

If you are interested, please send a cover letter (no more than 2 pages) that discusses your interest in the role and your experience in thoracic transplantation as well as your current CV.  Please send these two documents to [email protected] by October 17, 2025. 

3/4

[TransplantID Journal @TheTxIDjournal]

We are always looking for people willing to be reviewers for the journal - we have developed this survey to let you tell us if you are willing to be a reviewer and what topics you’d like to review on for @TheTxIDjournal!

@AST_IDCOP @ttsorg

https://t.co/jZXhgbgWgc

[TransplantID Journal @TheTxIDjournal]

So excited to see this CPC out from @JennCuellarR and colleagues from @NIAIDNews about a case of Acanthamoeba in an HSCT recipient. Exemplary case and great work finding the potential source.

https://t.co/bBQXND0Ba3

[TransplantID Journal @TheTxIDjournal]

@monicaslavin Lastly, we are also excited to welcome @benwteh as our newest Associate Editor with a focus on Onc ID/HSCT ID. Please help me in congratulating Ben on joining the editorial leadership team!

[TransplantID Journal @TheTxIDjournal]

As the year comes to an end its an opportunity to acknowledge all who have contributed to @TheTxIDjournal and to recognize changes in our editorial team.

We thank all of the reviewers and outline the key accomplishments of the journal in 2024 here:

https://t.co/ba0MSpwmY6

[TransplantID Journal @TheTxIDjournal]

We also want to thank @monicaslavin for her hard work and dedication as an Associate Editor and editor responsible for reviews. Monica is going to rotate off as associate editor and join our editorial board.

Please help me in thanking Monica!

[Adam Stewart @adm_stewart]

A fantastic Special Edition with some great papers in @TheTxIDjournal

[TransplantID Journal @TheTxIDjournal]

So excited to have the Donor-Derived Infection Special Edition out - thanks to @StephaniePouch and @karenmjwaller for being guest editors for this special edition!

https://t.co/UIX0gWhTHd

[TransplantID Journal @TheTxIDjournal]

This award is named after Bob Rubin, one of the early leaders in the field of #TxID. He was also the first editor of @TheTxIDjournal. He was passionate about defining the optimal approach to prevention and management of infections in ICHs.

[TransplantID Journal @TheTxIDjournal]

Congratulations to @nischalr3 and his team for their paper being selected as the @TheTxIDjournal 2024 Bob Rubin Clinical Impact Awardee - this award selects the paper felt to have the biggest impact on clinical care in #TxID!

Congrats!

https://t.co/9tP3g8kIpS

[transplantid.net @TransplantIDNet]

Kidney txp safe for patients on #tuberculosis treatment?

@TheTxIDjournal series 30 pt in India suggests yes!

2+ mos. RIPE➡️txp➡️rifamycin-free (quinolone) regimen

👍pt & graft survival!

Added by @AneelaMajeed5 ORGANISMS▶️BACTERIA▶️TUBERCULOSIS📂

https://t.co/WjgddJt41u

[TransplantID Journal @TheTxIDjournal]

Reminder - we will are looking for a new Associate Editor focused of HSCT/Oncology ID - see Tweet for detail - please submit CV and cover letter to [email protected] by November 8.

[TransplantID Journal @TheTxIDjournal]

@TheTxIDjournal is seeking applications for those interested in joining the editorial team as an Associate Editor.  We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position. 

https://t.co/AZP3ApiLVm

[TransplantID Journal @TheTxIDjournal]

Most recent issue is out for @TheTxIDjournal - lots of great papers but 3 focused on allergies:

A paper on the impact of sulfa-allergy labels on infection outcome & an experiences from the field about implementing delabeling from @TrubianoJason et al

https://t.co/da7oucrfTc

[AJT Editorial Fellows @AJTfellows]

Deadline is approaching!

[Michael Ison, MD MS @MichaelGIsonMD]

Want to learn the current state of the art for prevention of RVI in immunocompromised patients?

Join us for the next @ESCMID ESGICH/@esgrev_escmid webinar on the prevention of RVI.

Chaired by Elisa Cordero, Barbara Rath
Talks by @nesherl @MichaelGIsonMD @@JoshuaHillMD

[TransplantID Journal @TheTxIDjournal]

We continue to move papers previously rejected at other journals through quickly!

Got a paper that was rejected at another journal - consider @TheTxIDjournal instead of other journals. Its free and we’ll get your a decision generally within a few weeks.

[TransplantID Journal @TheTxIDjournal]

@TheTxIDjournal is pleased to announce that we are now accepting papers rejected from other journals with expedited review.

As opposed to some journals that charge over $3000/article, there is no publication fee @TheTxIDjournal.

https://t.co/Zmx0SmwKtQ

[Joshua Hill, MD @JoshuaHillMD]

Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark your calendars for May 11-14, 2025, for the 5th symposium on infections in immunocompromised individuals. Travel stipends available! https://t.co/qDLZEHRFh3